Lower Limb Ischemia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
ASC coated ePTFE vascular graftN/A1 trial
Active Trials
NCT01305863UnknownEst. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Genesis TherapeuticsASC coated ePTFE vascular graft

Clinical Trials (1)

NCT01305863Genesis TherapeuticsASC coated ePTFE vascular graft

Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft

Start: Feb 2011Est. completion: May 2022
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space